The neurodiagnostics market provides imaging systems, clinical instruments, reagents, and consumables used to diagnose neurological conditions. These technologies support the detection and monitoring of neurodegenerative diseases, stroke, epilepsy, headache disorders, sleep disorders, and other neurological conditions.

The market was valued at approximately USD 8.6 billion in 2024, about USD 9.78 billion in 2025, and is projected to reach roughly USD 20.36 billion by 2035, growing at a CAGR of approximately 7.6%. Growth is driven by an aging population, rising neurological disorders, demand for early diagnosis, AI adoption, blood-based biomarkers, and telehealth-based monitoring.marketresearchfuture

Neuroimaging technologies, including MRI, CT, and PET systems, represent a major product segment. Electrophysiology tools such as EEG, EMG, and evoked-potential systems are also widely used for epilepsy, sleep disorders, neuromuscular conditions, and intraoperative monitoring.

Neurodegenerative diseases represent a leading condition segment because of increasing Alzheimer’s and Parkinson’s disease prevalence. Stroke and epilepsy also generate strong demand for rapid and accurate diagnosis.

Hospitals and surgical centers are the largest end users. Diagnostic laboratories, imaging centers, neurology centers, ambulatory care facilities, research institutions, and academic institutes also contribute.

North America leads the market with more than 45% share, followed by Europe. Asia-Pacific is expected to grow rapidly because of hospital modernization, government neurotechnology programs, and increasing healthcare investment.

Key players include Siemens Healthineers, GE HealthCare, Philips Healthcare, Nihon Kohden, Natus Medical, Compumedics, Medtronic, and Cadwell Industries.

Read more: Neurodiagnostics Market Size, Share & Growth Report

People Also Ask

Q1. What are neurodiagnostics used for?
They are used to diagnose and monitor neurological conditions such as epilepsy, stroke, neurodegenerative diseases, sleep disorders, and brain injuries.

Q2. Which region leads the market?
North America leads because of advanced healthcare infrastructure, research investment, and high adoption of neurodiagnostic technologies.

Tags: neurodiagnostics, neurological disorders, MRI, EEG, neuroimaging, neurology